Sign up today to save time and keep current by receiving free, weekly science newsletters delivered directly to your inbox!
“I really enjoy your newsletters and look forward to receiving them.”
– Kathryn Futrega, B.Sc
Queensland University of Technology
“Thank you so much for your email and your great newsletters. My team and I really enjoy them, and I cover your “MSC news” in our group meeting each Monday.”
– Jan Nolta, PhD
Professor, UC Davis School of Medicine
“I often look forward to the weekly summaries from Connexon.”
– Kristopher Lofgren, PhD
Boston Children’s Hospital
“Great newsletter, especially like the weekly summary of articles in my field in my inbox so I don’t have to go looking for them.”
– Jennifer Adair, PhD, Fred Hutchinson Cancer Research Center and University of Washington
“I inadvertently got signed up for the newsletter. But because I found it so useful and informative, I have remained subscribed and actually recommended it to others.”
– Gregory Weber, PhD
Rutgers, The State University of New Jersey
“I have found these newsletters to be very valuable resources.”
– Dean Yamaguchi, MD, PhD
Associate Chief of Staff
VA Greater Los Angeles Healthcare System
About Cell Therapy News
Published every week since 2002, Cell Therapy News
is Connexon Creative’s longest running online publication, with over 450 issues published. We are proud to provide this highly valued resource to support the global cell therapy research community. By facilitating the communication of cutting edge cell therapy research, we save scientists time while keeping them current.
Cell Therapy News
provides free weekly updates of all areas of regenerative medicine. We highlight the top cell therapy, gene therapy and immunotherapy publications. Our editorial team curates the most current in vivo
research and reviews from high impact science journals, organizations and institutions. In addition, Cell Therapy News
provides extensive industry and policy news, as well as updates from various regulatory groups. Our newsletter also features job and event postings relating to the field of regenerative medicine.
With over 10,000 newsletter subscribers and over 3,400 Twitter
followers, Cell Therapy News
targets a wide audience from the scientific community including researchers, medical professionals and the biotechnology and pharmaceutical industries. In addition to providing our readers with content from top resources, we facilitate the exchange of science by giving researchers the opportunity to increase the exposure of their work by submitting their cell therapy publications, reviews, press releases, events and jobs to our editorial team.